Humana Inc. (NYSE:HUM) Receives Consensus Recommendation of “Hold” from Brokerages

Shares of Humana Inc. (NYSE:HUM) have received an average rating of “Hold” from the twenty-six research firms that are presently covering the company, MarketBeat.com reports. Three analysts have rated the stock with a sell rating, sixteen have issued a hold rating and seven have given a buy rating to the company. The average twelve-month target price among analysts that have issued ratings on the stock in the last year is $225.4783.

Several analysts recently commented on the stock. UBS Group reissued a “neutral” rating on shares of Humana in a research report on Wednesday, February 25th. Barclays decreased their target price on shares of Humana from $245.00 to $176.00 and set an “equal weight” rating for the company in a report on Tuesday, February 24th. Truist Financial cut their price target on shares of Humana from $285.00 to $200.00 and set a “hold” rating on the stock in a report on Tuesday, February 17th. Evercore reduced their price target on shares of Humana from $260.00 to $180.00 in a research report on Thursday, February 12th. Finally, Jefferies Financial Group decreased their price objective on shares of Humana from $310.00 to $235.00 and set a “buy” rating for the company in a report on Thursday, February 12th.

Insider Buying and Selling at Humana

In other Humana news, insider Sanjay K. Shetty purchased 810 shares of the stock in a transaction dated Monday, February 23rd. The shares were purchased at an average cost of $185.21 per share, with a total value of $150,020.10. Following the completion of the acquisition, the insider directly owned 11,657 shares in the company, valued at $2,158,992.97. This trade represents a 7.47% increase in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. 0.20% of the stock is owned by corporate insiders.

Hedge Funds Weigh In On Humana

A number of hedge funds have recently bought and sold shares of the business. Montag A & Associates Inc. boosted its holdings in shares of Humana by 1,880.0% during the 4th quarter. Montag A & Associates Inc. now owns 99 shares of the insurance provider’s stock valued at $25,000 after acquiring an additional 94 shares during the last quarter. CoreCap Advisors LLC raised its holdings in shares of Humana by 54.4% during the fourth quarter. CoreCap Advisors LLC now owns 105 shares of the insurance provider’s stock valued at $27,000 after purchasing an additional 37 shares during the last quarter. Fideuram Asset Management Ireland dac purchased a new position in shares of Humana during the fourth quarter valued at approximately $27,000. Reflection Asset Management bought a new position in Humana during the fourth quarter valued at approximately $29,000. Finally, Rosenberg Matthew Hamilton lifted its position in Humana by 136.0% during the fourth quarter. Rosenberg Matthew Hamilton now owns 118 shares of the insurance provider’s stock valued at $30,000 after purchasing an additional 68 shares during the period. Hedge funds and other institutional investors own 92.38% of the company’s stock.

Humana Stock Down 1.6%

HUM stock opened at $166.36 on Tuesday. The business has a 50 day moving average of $189.58 and a 200 day moving average of $237.60. The firm has a market cap of $19.97 billion, a PE ratio of 16.94, a price-to-earnings-growth ratio of 1.81 and a beta of 0.44. Humana has a twelve month low of $163.11 and a twelve month high of $315.35. The company has a quick ratio of 2.00, a current ratio of 2.00 and a debt-to-equity ratio of 0.70.

Humana (NYSE:HUM) last released its earnings results on Wednesday, February 11th. The insurance provider reported ($3.96) EPS for the quarter, topping analysts’ consensus estimates of ($4.01) by $0.05. Humana had a return on equity of 11.43% and a net margin of 0.92%.The firm had revenue of $32.64 billion for the quarter, compared to analysts’ expectations of $32.08 billion. During the same period in the prior year, the firm posted ($2.16) earnings per share. The company’s quarterly revenue was up 11.3% on a year-over-year basis. Humana has set its FY 2026 guidance at 9.000-9.000 EPS. On average, research analysts forecast that Humana will post 16.47 EPS for the current fiscal year.

Humana Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, April 24th. Shareholders of record on Friday, March 27th will be issued a $0.885 dividend. The ex-dividend date of this dividend is Friday, March 27th. This represents a $3.54 dividend on an annualized basis and a dividend yield of 2.1%. Humana’s dividend payout ratio (DPR) is presently 36.05%.

Humana Company Profile

Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.